Results 141 to 150 of about 18,078,412 (185)

From Physiology to Clinical Practice in Pancreatic Cancer-Related Thromboembolism-A Review. [PDF]

open access: yesCancers (Basel)
Jarowicz M   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A bleeding disorder due to deficiency of alpha 2-antiplasmin [PDF]

open access: yesBlood, 1982
A deficiency of alpha 2-antiplasmin has been identified in a female patient with severe and frequent bleeding episodes. Routine coagulation and platelet assays of the patient's plasma were within normal limits. However, abnormally rapid whole blood or dilute plasma clot lysis times and an abnormal FXIII test in which clots were lysed in the presence of
Ef Plow, C Hougie, Jh Griffin
exaly   +4 more sources

alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. [PDF]

open access: yesJournal of Clinical Investigation, 1987
alpha 2-Antiplasmin (alpha 2-AP) is a major fibrinolysis inhibitor, whose complete, congenital absence has been found to be associated with a distinct hemorrhagic diathesis. We studied a 15-yr-old male with a hemorrhagic diathesis after trauma from early childhood on.
D C Rijken, E Groeneveld, G Wijngaards
exaly   +3 more sources

The presence and release of alpha 2-antiplasmin from human platelets [PDF]

open access: yesBlood, 1981
An antigen immunochemically indistinguishable from plasma alpha 2- antiplasmin, the primary plasmin inhibitor, was detected in human platelets. By radioimmunoassay, 33–114 ng alpha 2-antiplasmin antigen was quantitated in the detergent-soluble extract of 10(9) washed human platelets from 10 normal donors with a mean level of 62 +/- 24 ng/10(9 ...
Ef Plow, Plow Ef, Collen D
exaly   +4 more sources

Alpha-2-Antiplasmin in Acute Nonlymphoblastic Leukemia

Acta Haematologica, 2009
The levels of alpha-2-antiplasmin (α<sub>2</sub>-AP), antithrombin III (At III) and plasminogen were studied in 21 patients with acute nonlymphoblastic leukemia (ANLL) before and after induction chemotherapy and during bone marrow cellularity recovery after the postchemotherapy aplastic phase.
E, Cofrancesco   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy